Description
SEBI releases Recovery Certificate No. 746 of 2015 against Bela H. Kayastha in the matter involving Aarti Industries Ltd., Aarti Drugs Ltd., Havells India Ltd., Lyka Labs Ltd. and Tasc Pharmaceuticals.
Summary
SEBI has issued a Release Order dated November 21, 2025 under Recovery Certificate No. 746 of 2015 drawn against Bela H. Kayastha. This order relates to enforcement proceedings in connection with Aarti Industries Ltd., Aarti Drugs Ltd., Havells India Ltd., Lyka Labs Ltd., and Tasc Pharmaceuticals. A release order typically indicates that the recovery obligations have been satisfied or proceedings are being concluded.
Key Points
- Release Order issued under Recovery Certificate No. 746 of 2015
- Order dated November 21, 2025
- Issued against: Bela H. Kayastha
- Related companies: Aarti Industries Ltd., Aarti Drugs Ltd., Havells India Ltd., Lyka Labs Ltd., and Tasc Pharmaceuticals
- Indicates conclusion or satisfaction of recovery proceedings
Regulatory Changes
No regulatory framework changes. This is an enforcement action specific to an individual case.
Compliance Requirements
No new compliance requirements for market participants. This order pertains to specific recovery proceedings against Bela H. Kayastha.
Important Dates
- Order Date: November 21, 2025
- Original Recovery Certificate: RC No. 746 of 2015
Impact Assessment
This release order has limited market-wide impact as it pertains to the conclusion of specific enforcement proceedings against an individual. The order does not impose new restrictions on the mentioned companies or broader market operations. Investors in the mentioned stocks (Aarti Industries, Aarti Drugs, Havells India) should note this as part of historical enforcement actions but it should not materially affect current operations or trading.
Impact Justification
Release order indicating completion or partial satisfaction of recovery proceedings against an individual. Limited market-wide impact as it pertains to specific enforcement action against Bela H. Kayastha.